Financials
- Market Capitalization 7.1 M
- Employee 8
- Founded 2017
- CEO N/A
- Website www.cnspharma.com
- Headquarter Nevada, United States
- FIGI BBG00PM24T16
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.15
ratio cours/chiffre d'affaires
-909.61
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4887 | IMRN Immuron Limited - American Depositary Shares | 1.24 USD | +1.64% | -4.62% | +7.83% | -36.41% | 7.25 M USD | ||
| 4888 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 5.80 USD | +1.58% | -8.52% | -7.50% | -35.56% | 7.15 M USD | ||
| 4892 | ERNA Ernexa Therapeutics Inc. - Common Stock | 6.06 USD | +9.39% | -5.75% | +0.50% | +1633.91% | 7.07 M USD | ||
| 4893 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.65 USD | +4.43% | +13.79% | +1.85% | -14.06% | 7.09 M USD |